4/6/2011

Dr. Reddy's Laboratories subsidiary Promius Pharma agreed to purchase U.S. development and marketing rights to Cloderm, Valeant Pharmaceuticals International's topical drug for skin disorders. Valeant will receive an upfront fee as well as royalties.

Full Story:
MSN

Related Summaries